20162017201820192020202120222023Billable/Specific Code
- C83.94 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM C83.94 became effective on October 1, 2022.
- This is the American ICD-10-CM version of C83.94 – other international versions of ICD-10 C83.94 may differ.
ICD-10-CM C83.94 is grouped within Diagnostic Related Group(s):
- 820 Lymphoma and leukemia with major o. R. Procedures with mcc
- 821 Lymphoma and leukemia with major o. R. Procedures with cc
- 822 Lymphoma and leukemia with major o. R. Procedures without cc/mcc
- 823 Lymphoma and non-acute leukemia with other procedures with mcc
- 824 Lymphoma and non-acute leukemia with other procedures with cc
- 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
- 840 Lymphoma and non-acute leukemia with mcc
- 841 Lymphoma and non-acute leukemia with cc
- 842 Lymphoma and non-acute leukemia without cc/mcc
- 974 Hiv with major related condition with mcc
- 975 Hiv with major related condition with cc
- 976 Hiv with major related condition without cc/mcc
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to C83.94:
